We use cookies to personalize content and to analyze our traffic. Please decide if you are willing to accept cookies from our website.

ORI Capital

As a healthcare fund, we hope to be both financially successful and socially impactful

Our Team

Founder & Senior Partner

Simone Song

Partner

Dicky To

Director

Elaine Yang

Approach-specific Scientist

Otto Cheung

Approach-specific Scientist

Sarah Mak

Approach-specific Scientist

Evangeline Kang

Approach-specific Scientist

Daniel Zhang

Data Scientist

Nico Zheng

Data Engnieer

Mia Zheng

Legal Counsel

Edward Tung

Financial Controller

Cathy Choi

HR & Office Manager

Gillian Zhou

Personal Assistant

Wendy Wang

Our Portfolio

Exited

Read More
The only company to date that can apply stem cell therapy to cure type 1 diabetes
Read More
World’s first fully humanized antibodies selection platform generating disease-modifying drugs

Listed

NASDAQ:ORTX
Read More
World’s leading gene therapy company targeting multiple diseases with limited or no existing treatment

The first ever high-volume biologic injector

The only company to date that can deliver drugs to pancreatic tumors using its innovative delivery device

First IVD company in tumor testing space making precision medicine the first-line treatment

The leading oncolytic virus company in Phase 3 bladder cancer

Developing CAR-T therapy focusing on brand new target for solid tumor

The world’s first cloud-based platform for AI medical imaging analysis

Cutting edge anti-aging nutraceutical company